NEUEHEALTH INC (NEUE) Stock Analyst Earnings Estimates
NYSE:NEUE - New York Stock Exchange, Inc. - US10920V4041 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.513B 193.84% | 2.412B 59.42% | 1.161B -51.87% | 974.04M -16.09% | 1.066B 9.44% | 1.138B 6.75% | |
| EBITDA YoY % growth | -306M -94.78% | -424.4M -38.69% | -144.454M 65.96% | 19.726M 113.66% | 35.564M 80.29% | 46.92M 31.93% | |
| EBIT YoY % growth | -341.5M -106.47% | -475M -39.09% | -168.621M 64.50% | -95.88M 43.14% | -58.293M 39.20% | -39.984M 31.41% | |
| Operating Margin | -22.57% | -19.69% | -14.53% | -9.84% | -5.47% | -3.51% | |
| EPS YoY % growth | N/A | -128.80 -11.32% | -6.86 94.67% | -15.70 -128.83% | -12.16 22.55% | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -4.41 -121.98% |
| Revenue Q2Q % growth | 256.9M -12.28% |
| EBITDA Q2Q % growth | 817.02K 103.77% |
| EBIT Q2Q % growth | -23.307M 49.12% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -3.92 54.04% | -3.16 | -0.76 | -23.97% |
| Q2 2024 Q2Q % growth | -7.27 -82.66% | -3.33 | -3.94 | -118.63% |
| Q1 2024 Q2Q % growth | -7.54 47.64% | -5.41 | -2.13 | -39.47% |
| Q4 2023 Q2Q % growth | 20.05 173.71% | -4.24 | 24.29 | 572.52% |
| Q3 2023 Q2Q % growth | -8.53 78.68% | -4.45 | -4.08 | -91.81% |
| Q2 2023 Q2Q % growth | -3.98 88.94% | -5.55 | 1.57 | 28.34% |
| Q1 2023 Q2Q % growth | -14.40 43.75% | -7.75 | -6.65 | -85.76% |
| Q4 2022 Q2Q % growth | -27.20 -2,008.53% | -41.62 | 14.42 | 34.64% |
| Q3 2022 Q2Q % growth | -40.00 -8,233.33% | -29.70 | -10.30 | -34.67% |
| Q2 2022 Q2Q % growth | -36.00 -12,757.14% | -26.30 | -9.70 | -36.87% |
| Q1 2022 Q2Q % growth | -25.60 | -19.73 | -5.87 | -29.76% |
| Q4 2021 Q2Q % growth | -1.29 | -0.46 | -0.83 | -181.40% |
| Q3 2021 Q2Q % growth | -0.48 | -0.15 | -0.33 | -226.05% |
| Q2 2021 Q2Q % growth | -0.28 | -0.16 | -0.12 | -71.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 232.933M -13.54% | 239.58M | -6.647M | -2.77% |
| Q2 2024 Q2Q % growth | 225.991M -69.77% | 257.53M | -31.539M | -12.25% |
| Q1 2024 Q2Q % growth | 245.095M -67.59% | 253.48M | -8.385M | -3.31% |
| Q4 2023 Q2Q % growth | 292.871M -84.49% | 289.11M | 3.761M | 1.30% |
| Q3 2023 Q2Q % growth | 269.399M 39.30% | 290.1M | -20.701M | -7.14% |
| Q2 2023 Q2Q % growth | 747.68M 400.79% | 767.09M | -19.41M | -2.53% |
| Q1 2023 Q2Q % growth | 756.341M 318.33% | 787.96M | -31.619M | -4.01% |
| Q4 2022 Q2Q % growth | 1.889B 221.53% | 1.764B | 124.6M | 7.06% |
| Q3 2022 Q2Q % growth | 193.4M -82.07% | 1.802B | -1.609B | -89.27% |
| Q2 2022 Q2Q % growth | 149.3M -86.60% | 1.849B | -1.7B | -91.93% |
| Q1 2022 Q2Q % growth | 180.8M -79.33% | 1.78B | -1.599B | -89.84% |
| Q4 2021 Q2Q % growth | -1.554B -367.09% | 1.102B | -2.656B | -241.02% |
| Q3 2021 Q2Q % growth | 1.079B 206.36% | 1.106B | -27.3M | -2.47% |
| Q2 2021 Q2Q % growth | 1.114B 275.14% | 1.059B | 54.8M | 5.17% |
| Q1 2021 Q2Q % growth | 874.6M 340.38% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | -1.18% |